Propofol hemisuccinate suppresses cortical spreading depression

Ashish Dhir, Christoph Lossin, Michael A Rogawski

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Propofol is a rapidly acting water-insoluble non-barbiturate anesthetic agent that is widely used as an intravenous sedative-hypnotic agent. Anecdotal evidence indicates that propofol may be effective at terminating intractable migraine headache. Cortical spreading depression (CSD) is believed to be the neural correlate of migraine aura and may be a trigger for migraine pain. Agents that block the induction or slow the spread of CSD may be of utility in treating migraine. Here we examined the ability of propofol hemisuccinate (PHS), a water-soluble prodrug of propofol, to affect CSD in mice. For comparison, we examinined dizocilpine, an NMDA receptor antagonist, that is well recognized to inhibit CSD. When administered 15. min prior to activation of CSD by KCl application to the cortex, intraperitoneal PHS at doses of 120 and 200. mg/kg decreased the number of CSD deflections without an effect on CSD amplitude, and at 200. mg/kg caused a 77% reduction in CSD velocity. The minimally-effective dose of PHS (120. mg/kg) did not cause sedation or motor impairment and while some animals receiving 200. mg/kg did demonstrate motor impariment none exhibited loss-of-righting reflex (anesthesia). Dizocilpine produced comparable inhibition of CSD at doses of 0.5 and 2.5. mg/kg. We conclude that acute PHS treatment inhibits CSD. Our results indicate that propofol, or its prodrug PHS, are worthy of further investigation as a treatment for migraine.

Original languageEnglish (US)
Pages (from-to)67-70
Number of pages4
JournalNeuroscience Letters
Volume514
Issue number1
DOIs
StatePublished - Apr 11 2012

Fingerprint

Cortical Spreading Depression
Propofol
Migraine Disorders
Dizocilpine Maleate
Prodrugs
Righting Reflex
Headache Disorders
Aptitude
Water
N-Methyl-D-Aspartate Receptors
Hypnotics and Sedatives
Anesthetics
Epilepsy
Anesthesia

Keywords

  • Cortical spreading depression
  • Dizocilpine
  • Migraine
  • Propofol hemisuccinate

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Propofol hemisuccinate suppresses cortical spreading depression. / Dhir, Ashish; Lossin, Christoph; Rogawski, Michael A.

In: Neuroscience Letters, Vol. 514, No. 1, 11.04.2012, p. 67-70.

Research output: Contribution to journalArticle

Dhir, Ashish ; Lossin, Christoph ; Rogawski, Michael A. / Propofol hemisuccinate suppresses cortical spreading depression. In: Neuroscience Letters. 2012 ; Vol. 514, No. 1. pp. 67-70.
@article{8f3e7de9d1c54734a876bb066cc3f15b,
title = "Propofol hemisuccinate suppresses cortical spreading depression",
abstract = "Propofol is a rapidly acting water-insoluble non-barbiturate anesthetic agent that is widely used as an intravenous sedative-hypnotic agent. Anecdotal evidence indicates that propofol may be effective at terminating intractable migraine headache. Cortical spreading depression (CSD) is believed to be the neural correlate of migraine aura and may be a trigger for migraine pain. Agents that block the induction or slow the spread of CSD may be of utility in treating migraine. Here we examined the ability of propofol hemisuccinate (PHS), a water-soluble prodrug of propofol, to affect CSD in mice. For comparison, we examinined dizocilpine, an NMDA receptor antagonist, that is well recognized to inhibit CSD. When administered 15. min prior to activation of CSD by KCl application to the cortex, intraperitoneal PHS at doses of 120 and 200. mg/kg decreased the number of CSD deflections without an effect on CSD amplitude, and at 200. mg/kg caused a 77{\%} reduction in CSD velocity. The minimally-effective dose of PHS (120. mg/kg) did not cause sedation or motor impairment and while some animals receiving 200. mg/kg did demonstrate motor impariment none exhibited loss-of-righting reflex (anesthesia). Dizocilpine produced comparable inhibition of CSD at doses of 0.5 and 2.5. mg/kg. We conclude that acute PHS treatment inhibits CSD. Our results indicate that propofol, or its prodrug PHS, are worthy of further investigation as a treatment for migraine.",
keywords = "Cortical spreading depression, Dizocilpine, Migraine, Propofol hemisuccinate",
author = "Ashish Dhir and Christoph Lossin and Rogawski, {Michael A}",
year = "2012",
month = "4",
day = "11",
doi = "10.1016/j.neulet.2012.02.058",
language = "English (US)",
volume = "514",
pages = "67--70",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Propofol hemisuccinate suppresses cortical spreading depression

AU - Dhir, Ashish

AU - Lossin, Christoph

AU - Rogawski, Michael A

PY - 2012/4/11

Y1 - 2012/4/11

N2 - Propofol is a rapidly acting water-insoluble non-barbiturate anesthetic agent that is widely used as an intravenous sedative-hypnotic agent. Anecdotal evidence indicates that propofol may be effective at terminating intractable migraine headache. Cortical spreading depression (CSD) is believed to be the neural correlate of migraine aura and may be a trigger for migraine pain. Agents that block the induction or slow the spread of CSD may be of utility in treating migraine. Here we examined the ability of propofol hemisuccinate (PHS), a water-soluble prodrug of propofol, to affect CSD in mice. For comparison, we examinined dizocilpine, an NMDA receptor antagonist, that is well recognized to inhibit CSD. When administered 15. min prior to activation of CSD by KCl application to the cortex, intraperitoneal PHS at doses of 120 and 200. mg/kg decreased the number of CSD deflections without an effect on CSD amplitude, and at 200. mg/kg caused a 77% reduction in CSD velocity. The minimally-effective dose of PHS (120. mg/kg) did not cause sedation or motor impairment and while some animals receiving 200. mg/kg did demonstrate motor impariment none exhibited loss-of-righting reflex (anesthesia). Dizocilpine produced comparable inhibition of CSD at doses of 0.5 and 2.5. mg/kg. We conclude that acute PHS treatment inhibits CSD. Our results indicate that propofol, or its prodrug PHS, are worthy of further investigation as a treatment for migraine.

AB - Propofol is a rapidly acting water-insoluble non-barbiturate anesthetic agent that is widely used as an intravenous sedative-hypnotic agent. Anecdotal evidence indicates that propofol may be effective at terminating intractable migraine headache. Cortical spreading depression (CSD) is believed to be the neural correlate of migraine aura and may be a trigger for migraine pain. Agents that block the induction or slow the spread of CSD may be of utility in treating migraine. Here we examined the ability of propofol hemisuccinate (PHS), a water-soluble prodrug of propofol, to affect CSD in mice. For comparison, we examinined dizocilpine, an NMDA receptor antagonist, that is well recognized to inhibit CSD. When administered 15. min prior to activation of CSD by KCl application to the cortex, intraperitoneal PHS at doses of 120 and 200. mg/kg decreased the number of CSD deflections without an effect on CSD amplitude, and at 200. mg/kg caused a 77% reduction in CSD velocity. The minimally-effective dose of PHS (120. mg/kg) did not cause sedation or motor impairment and while some animals receiving 200. mg/kg did demonstrate motor impariment none exhibited loss-of-righting reflex (anesthesia). Dizocilpine produced comparable inhibition of CSD at doses of 0.5 and 2.5. mg/kg. We conclude that acute PHS treatment inhibits CSD. Our results indicate that propofol, or its prodrug PHS, are worthy of further investigation as a treatment for migraine.

KW - Cortical spreading depression

KW - Dizocilpine

KW - Migraine

KW - Propofol hemisuccinate

UR - http://www.scopus.com/inward/record.url?scp=84859001837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859001837&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2012.02.058

DO - 10.1016/j.neulet.2012.02.058

M3 - Article

VL - 514

SP - 67

EP - 70

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1

ER -